Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1445751-71-2
|
| gptkbp:class |
recreational drug
opioid |
| gptkbp:effect |
analgesic
opioid-like effects |
| gptkbp:hasMolecularFormula |
C20H23NO2
|
| gptkbp:hasPotentialForAbuse |
yes
|
| gptkbp:hasRelatedCompound |
gptkb:U-47700
AH-7921 |
| gptkbp:hasYearOfFirstReport |
2019
|
| https://www.w3.org/2000/01/rdf-schema#label |
BGP-2
|
| gptkbp:IUPACName |
1-(2-methoxyphenyl)-N-[(2-methylphenyl)methyl]cyclopropanecarboxamide
|
| gptkbp:legalStatus |
controlled substance in some jurisdictions
|
| gptkbp:PubChem_CID |
118796632
|
| gptkbp:routeOfAdministration |
oral
intravenous intranasal |
| gptkbp:bfsParent |
gptkb:BGP-3
|
| gptkbp:bfsLayer |
7
|